» Articles » PMID: 34261457

Morbidity and Mortality After Liver Surgery for Colorectal Liver Metastases: a Cohort Study in a High-volume Fast-track Programme

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2021 Jul 15
PMID 34261457
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: For colorectal liver metastases, surgery is a high-risk procedure due to perioperative morbidity. The objective was to assess severity of complications after fast-track liver surgery for colorectal liver metastases and their impact on morbidity and mortality.

Methods: All patients were treated according to the same fast-track programme. Complications were graded according to the Clavien-Dindo classification for patients undergoing surgery from 2013 to 2015. Correlation between complications and length of stay was analysed by multivariate linear regression.

Results: 564 patient cases were included of which three patients died within 3 months (0.53%, 95% CI: 0.17-1.64%). Complications were common with Grade ≤ 2 in 167 patients (30%) and ≥ Grade 3a in 93 (16%). Patients without complications had a mean length of stay of 4.1 days, which increased with complications: 1.4 days (95% CI: 1.3-1.5) for Grade 2, 1.7 days (1.5-2.0) for Grade 3a, 2.3 days (1.7-3.0) for Grade 3b, 2.6 days (1.6-4.2) for Grade 4a, and 2.9 days (2.8-3.1) for Grade 4b. Following were associated with increased length of stay: complication severity grade, liver insufficiency, ascites, biliary, cardiopulmonary, and infectious complications.

Conclusions: Complications after liver surgery for colorectal liver metastases, in a fast track setting, were associated with low mortality, and even severe complications only prolonged length of stay to a minor degree.

Citing Articles

Laparoscopic ablation for liver malignancies: initial experience at a Scandinavian high volume HPB center.

Klubien J, Knofler L, Larsen P, Nielsen S, Fukumori D, Hillingso J Surg Endosc. 2024; 38(10):5785-5792.

PMID: 39145873 PMC: 11458709. DOI: 10.1007/s00464-024-11125-x.


Propensity-score matched outcomes of resection of stage IV primary colon cancer with and without simultaneous resection of liver metastases.

Emile S, Horesh N, Garoufalia Z, Gefen R, Zhou P, Wexner S Updates Surg. 2024; 76(3):845-853.

PMID: 38568358 PMC: 11130067. DOI: 10.1007/s13304-024-01832-4.


Evaluation of the validated intraoperative bleeding scale in liver surgery: study protocol for a multicenter prospective study.

Aparicio-Lopez D, Asencio-Pascual J, Blanco-Fernandez G, Cugat-Andorra E, Gomez-Bravo M, Lopez-Ben S Front Surg. 2023; 10:1223225.

PMID: 37850041 PMC: 10577188. DOI: 10.3389/fsurg.2023.1223225.


Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples.

Stulpinas R, Zilenaite-Petrulaitiene D, Rasmusson A, Gulla A, Grigonyte A, Strupas K Cancers (Basel). 2023; 15(2).

PMID: 36672317 PMC: 9857181. DOI: 10.3390/cancers15020366.


Impact of perioperative steroid administration in patients undergoing elective liver resection: meta-analysis.

Jotten L, Steinkraus K, Traub B, Graf S, Mihaljevic A, Kornmann M BJS Open. 2022; 6(6).

PMID: 36537738 PMC: 9764439. DOI: 10.1093/bjsopen/zrac139.

References
1.
Halls M, Cipriani F, Berardi G, Barkhatov L, Lainas P, Alzoubi M . Conversion for Unfavorable Intraoperative Events Results in Significantly Worse Outcomes During Laparoscopic Liver Resection: Lessons Learned From a Multicenter Review of 2861 Cases. Ann Surg. 2017; 268(6):1051-1057. DOI: 10.1097/SLA.0000000000002332. View

2.
Wang P, Chen Z, Huang W, Liu L . Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials. World J Gastroenterol. 2005; 11(25):3817-22. PMC: 4504878. DOI: 10.3748/wjg.v11.i25.3817. View

3.
Kanas G, Taylor A, Primrose J, Langeberg W, Kelsh M, Mowat F . Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012; 4:283-301. PMC: 3496330. DOI: 10.2147/CLEP.S34285. View

4.
Gaillard M, Tranchart H, Dagher I . Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations. World J Gastroenterol. 2014; 20(17):4892-9. PMC: 4009520. DOI: 10.3748/wjg.v20.i17.4892. View

5.
Simillis C, Constantinides V, Tekkis P, Darzi A, Lovegrove R, Jiao L . Laparoscopic versus open hepatic resections for benign and malignant neoplasms--a meta-analysis. Surgery. 2007; 141(2):203-211. DOI: 10.1016/j.surg.2006.06.035. View